Key Takeaways
- PBM price transparency rules are not expected to fall away with President Trump wanting to ensure they are enforced.
- More legal wrangling over the rules may occur, but may be impacted by the broader PBM reform landscape.
- Experts said PBMs should become familiar with the transparency standards to prepare for data to be released.
While a previous effort to force the disclosure of net drug prices was scuttled amid legal challenges, President Donald Trump recently made it clear that he hopes to revisit the...
“There’s no more hope that this will go away,” said Chris O’Dell, senior vice president of market solutions at Turquoise Health, a company that cleans and aggregates pricing data from...